5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 190.17▲ | 185.65▲ |
MA10 | N/A | N/A | N/A | 188.16▲ | 183.77▲ |
MA20 | N/A | N/A | N/A | 185.77▲ | 192.58▼ |
MA50 | N/A | N/A | N/A | 186.01▲ | 187.61▲ |
MA100 | N/A | N/A | N/A | 191.78▲ | 173.09▲ |
MA200 | N/A | N/A | N/A | 188.75▲ | 157.58▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.956▲ | -0.744▼ |
RSI | N/A | N/A | N/A | 59.536▲ | 52.532▲ |
STOCH | N/A | N/A | N/A | 91.175▲ | 46.491 |
WILL %R | N/A | N/A | N/A | 0.000▲ | -50.176 |
CCI | N/A | N/A | N/A | 120.626▲ | 0.672 |
Wednesday, November 20, 2024 04:00 PM
Fintel reports that on November 22, 2024, Leerink Partners upgraded their outlook for AbbVie (LSE:0QCV) from Market Perform to Outperform. As of November 21, 2024, the average one-year price ...
|
Wednesday, November 20, 2024 04:00 PM
Fintel reports that on November 22, 2024, Leerink Partners upgraded their outlook for AbbVie (LSE:0QCV) from Market Perform to Outperform. As of November 21, 2024, the average one-year price ...
|
Tuesday, October 22, 2024 05:00 PM
Fintel reports that on November 4, 2024, Argus Research upgraded their outlook for AbbVie (LSE:0QCV) from Hold to Buy. As of October 23, 2024, the average one-year price target for AbbVie is 205. ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/06/25 | 192.05 | 192.05 | 188.29 | 192.05 | 28 |
11/06/25 | 189.40 | 191.60 | 188.29 | 191.60 | 26 |
10/06/25 | 189.20 | 190.10 | 188.29 | 190.10 | 18 |
09/06/25 | 189.40 | 189.96 | 188.29 | 189.40 | 109 |
06/06/25 | 187.70 | 189.96 | 187.70 | 187.70 | 781 |
05/06/25 | 187.50 | 187.50 | 187.50 | 187.50 | 134 |
04/06/25 | 188.20 | 188.60 | 184.43 | 188.60 | 96 |
03/06/25 | 186.50 | 186.50 | 184.43 | 186.50 | 43 |
02/06/25 | 185.66 | 185.66 | 184.43 | 184.60 | 70 |
30/05/25 | 184.80 | 185.66 | 183.50 | 183.50 | 1,847 |
|
|
||||
|
|
||||
|
|